Increase in Autologous HSCT for Myeloma, Decline in Allogeneic Increase in Autologous HSCT for Myeloma, Decline in Allogeneic

Autologous hematopoietic stem cell transplants have increased globally, but predominantly in high income nations, and there are marked disparities in usage.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news